Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous melanocyte transfer plus PUVA therapy versus PUVA therapy alone in vitiligo
IRCT138706111159N1Phase 3Completed
- Sponsor
- Iran National Science Foundation
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of psoralen in Vitiligo, sponsored by Iran National Science Foundation. Started Aug 2007; status: completed.
02
Drugs
psoralen
03
Conditions
Vitiligo
Beyond the preview
Go deeper on IRCT138706111159N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138706111159N1.